Physician profile
Himanshu MD Agarwal
NPI 1942280672
$541,240.74
in general payments reported to CMS, 2019-2025
40 companies · $105K in 2025
The $105K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $22K · 2021: $4,650 · 2022: $52K · 2023: $167K · 2024: $137K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $311K · Travel and Lodging: $50K · Food and Beverage: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $311,004.50 |
| Travel and Lodging | $49,556.53 |
| Food and Beverage | $25,504.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,362.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $412,974.39 | 2019-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Amplatzer Talisman |
| Edwards Lifesciences Corporation | $32,464.63 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Evoque |
| Janssen Pharmaceuticals, INC | $26,301.24 | 2019-2022 | |
| Amarin Pharma, INC. | $22,174.02 | 2019-2020 | |
| Medtronic, INC. | $17,350.04 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $13,338.19 | 2019-2020 | |
| Boston Scientific Corporation | $7,841.92 | 2019-2025 | General - Therapies, Rotablator Rotational Atherectomy System Console Kit, Avvigo Guidance System |
| Shockwave Medical, INC | $1,997.94 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $1,251.19 | 2019-2024 | (9525) Intracardiac Und, (Ao0) Igt Devices Intracardiac, (9148) Ice 3d |
| Abiomed | $1,037.61 | 2019-2025 | Impella |
| W. L. Gore & Associates, INC. | $633.69 | 2019-2020 | |
| Saranas, INC. | $527.33 | 2022 | |
| Teleflex LLC | $339.39 | 2022-2025 | Manta, Guideliner, Turnpike |
| Cardiva Medical, INC. | $302.08 | 2021-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Siemens Medical Solutions USA, INC. | $226.98 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Himanshu Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.